Cargando…
Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System
PURPOSE: Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic tumors treated in the public health system in Brazil do not have access to trastuzumab. This study aimed to estimate the impact of the lack of access to anti-HER2 therapies on the mortality of these patients....
Autores principales: | Debiasi, Márcio, Reinert, Tomás, Kaliks, Rafael, Amorim, Gilberto, Caleffi, Maira, Sampaio, Carlos, Fernandes, Gustavo dos Santos, Barrios, Carlos H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493223/ https://www.ncbi.nlm.nih.gov/pubmed/28717761 http://dx.doi.org/10.1200/JGO.2016.005678 |
Ejemplares similares
-
Lack of access to CDK4/6 inhibitors for premenopausal patients with metastatic breast cancer in Brazil: estimation of the number of premature deaths
por: Reinert, Tomás, et al.
Publicado: (2020) -
Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab
por: Barrios, Carlos Henrique, et al.
Publicado: (2019) -
Estimation of the Number of Brazilian Women Living With Metastatic Breast Cancer
por: Reinert, Tomás, et al.
Publicado: (2020) -
Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: review
por: Reinert, Tomás, et al.
Publicado: (2017) -
Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis
por: Debiasi, Márcio, et al.
Publicado: (2018)